Improving post-natal detection of mitochondrial DNA mutations

Area of Science:

• Genetics
• Molecular Biology
• Mitochondrial Diseases

Background:

• Genetic testing for mitochondrial DNA mutations traditionally involves screening for various alterations.
• Next-generation sequencing (NGS) has significantly advanced the diagnosis and understanding of mitochondrial diseases (MD) in the past decade.
• NGS is now a standard component of the diagnostic workup for MD.

Purpose of the Study:

• To provide an overview of current technologies for the molecular diagnosis of mitochondrial DNA diseases.
• To highlight the recent impact of NGS testing on the diagnosis and comprehension of MD.

Main Methods:

• Utilizes next-generation sequencing (NGS) technologies.
• Employs protocols for simultaneous analysis of mitochondrial and nuclear DNA.
• Leverages NGS for mutation detection and heteroplasmy level quantification.

Main Results:

• NGS enables sensitive and specific detection of mitochondrial DNA point mutations.
• Simultaneous detection of mutations and quantification of heteroplasmy levels are achievable with NGS.
• Efficient and cost-saving NGS protocols for analyzing both mitochondrial and nuclear DNA are available.

Conclusions:

• NGS technologies have become the gold standard in diagnostic laboratories for mitochondrial DNA disease testing.
• NGS offers efficient, sensitive, and specific molecular diagnostic approaches for MD.
• The integration of NGS has transformed the diagnostic landscape for mitochondrial diseases.